使用当代MRI质子密度脂肪分数测量方法诊断肝脂肪变性的截断值
该回顾性研究以2015至2018年间1063例成人肝移植供体候选者为对象,以组织学脂肪分数(HFF)≥5%为参考标准,在开发集(497例)中确定CS-MRI-PDFF与HISTO-MRS-PDFF的排除与确诊肝脂肪变性截断值,并在验证集(424例)中评估诊断性能。
要点
- 排除肝脂肪变性:CS-MRI-PDFF截断值2.3%(敏感度92.4%,特异度63.0%),HISTO-MRS-PDFF截断值2.6%(敏感度88.8%,特异度70.1%)。
- 确诊肝脂肪变性:CS-MRI-PDFF截断值3.5%(敏感度73.5%,特异度88.6%),HISTO-MRS-PDFF截断值4.0%(敏感度74.7%,特异度90.6%)。
- 开发集中诊断肝脂肪变性的ROC曲线下面积:CS-MRI-PDFF为0.920,HISTO-MRS-PDFF为0.915。
核心结论
- 在大量健康成人中,本研究针对以HFF≥5%定义的肝脂肪变性,提出了当代PDFF测量方法的排除与确诊诊断阈值。
研究设计与样本
- 回顾性研究,纳入2015至2018年间1063例成人肝移植供体候选者,最终分析921例(男624例;平均年龄±标准差31.5±9.0岁),按时间分割为开发集497例和验证集424例;采用化学位移成像MRI(CS-MRI)PDFF和高速T2校正多回波MR波谱(HISTO-MRS)PDFF,以组织学脂肪分数(HFF)为参考标准。
诊断标准与关键数值
- 排除肝脂肪变性(参考HFF≥5%):CS-MRI-PDFF截断值2.3%(敏感度92.4%,特异度63.0%),HISTO-MRS-PDFF截断值2.6%(敏感度88.8%,特异度70.1%)。
- 确诊肝脂肪变性(参考HFF≥5%):CS-MRI-PDFF截断值3.5%(敏感度73.5%,特异度88.6%),HISTO-MRS-PDFF截断值4.0%(敏感度74.7%,特异度90.6%)。
- 开发集诊断肝脂肪变性的ROC曲线下面积:CS-MRI-PDFF为0.920,HISTO-MRS-PDFF为0.915。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To propose standardized MRI-proton density fat fraction (PDFF) cutoff values for diagnosing hepatic steatosis, evaluated using contemporary PDFF measuring methods in a large population of healthy adults, using histologic fat fraction (HFF) as the reference standard.
MATERIALS AND METHODS: A retrospective search of electronic medical records between 2015 and 2018 identified 1063 adult donor candidates for liver transplantation who had undergone liver MRI and liver biopsy within a 7-day interval. Patients with a history of liver disease or significant alcohol consumption were excluded. Chemical shift imaging-based MRI (CS-MRI) PDFF and high-speed T2-corrected multi-echo MR spectroscopy (HISTO-MRS) PDFF data were obtained. By temporal splitting, the total population was divided into development and validation sets. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic performance of the MRI-PDFF method. Two cutoff values with sensitivity > 90% and specificity > 90% were selected to rule-out and rule-in, respectively, hepatic steatosis with reference to HFF ≥ 5% in the development set. The diagnostic performance was assessed using the validation set.
RESULTS: Of 921 final participants (624 male; mean age ± standard deviation, 31.5 ± 9.0 years), the development and validation sets comprised 497 and 424 patients, respectively. In the development set, the areas under the ROC curve for diagnosing hepatic steatosis were 0.920 for CS-MRI-PDFF and 0.915 for HISTO-MRS-PDFF. For ruling-out hepatic steatosis, the CS-MRI-PDFF cutoff was 2.3% (sensitivity, 92.4%; specificity, 63.0%) and the HISTO-MRI-PDFF cutoff was 2.6% (sensitivity, 88.8%; specificity, 70.1%). For ruling-in hepatic steatosis, the CS-MRI-PDFF cutoff was 3.5% (sensitivity, 73.5%; specificity, 88.6%) and the HISTO-MRI-PDFF cutoff was 4.0% (sensitivity, 74.7%; specificity, 90.6%).
CONCLUSION: In a large population of healthy adults, our study suggests diagnostic thresholds for ruling-out and ruling-in hepatic steatosis defined as HFF ≥ 5% by contemporary PDFF measurement methods.
引用
- Park S, Kwon JH, Kim SY, et al. Cutoff Values for Diagnosing Hepatic Steatosis Using Contemporary MRI-Proton Density Fat Fraction Measuring Methods. Korean J Radiol. 2022. PMID: 36447414. doi:10.3348/kjr.2022.0334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。